Executive record

Alpna Seth

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:alpna-sethVersion: public-0As of: 2026-09-28

Not yet claimed8 published Claims2 sources

Key Claims

Biography

Former CEO of Nura Bio and COO of Vir Biotechnology. Extensive experience in drug discovery, R&D, and international operations in the pharmaceutical industry.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Claims

Conflicts and accountability

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. TECH DEF 14A director slate

    sec filing · Source published: Sep 19, 2025 · Retrieved: Apr 29, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Board role: Board role: Director · Claim reviewed: Apr 29, 2026
    • Committee assignments: Committee assignments: Nominating/Governance, Science/Innovation · Claim reviewed: Apr 29, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: Apr 29, 2026

  2. Bio-Techne Corporation director board source

    sec filing · Source published: Sep 19, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Bio-Techne Corporation · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026